The Filings Report

Omega Healthcare Investors Inc.

OHINYSECIK 888491Real Estate / REITsfiscal year ends December69 quarters since 2009

Revenue, Q2 FY2026
$14M
−95.0% on Q2 FY2025
Net income
$363M
+165.6% on Q2 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$1.19
+158.7% on Q2 FY2025
Revenue, TTM
$651M
trailing four quarters
Net margin, TTM
131.8%
net income $858M
Free cash flow, TTM
—
Cash and equivalents
$39M
long-term debt —, Jun 30, 2026
Shares, 12-month change
+2.7%
303M shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$795M
5.6% of market value
Market value
$14.2B
at the close, buybacks

Latest quarter Q2 FY2026, filed July 30, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Omega Healthcare Investors Inc. reported revenue of $14M, −95.0% on Q2 FY2025, and net income of $363M (+165.6%). Net income this quarter is driven by non-operating items: $239M of other income against $331M of operating income, so it reflects gains or losses outside the operations. Operating margin was 2365.9%. Diluted earnings per share were $1.19.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of July 30, 2026.

Revenue and net incomeRevenueNet income
$0$100M$200M$300M$400MQ3'22, Revenue: $239MQ3'22, Net income: $102MQ3'22Q4'22, Revenue: $145MQ4'22, Net income: $46MQ4'22Q1'23, Revenue: $218MQ1'23, Net income: $36MQ1'23Q2'23, Revenue: $250MQ2'23, Net income: $60MQ2'23Q3'23, Revenue: $242MQ3'23, Net income: $91MQ3'23Q4'23, Revenue: $239MQ4'23, Net income: $55MQ4'23Q1'24, Revenue: $243MQ1'24, Net income: $67MQ1'24Q2'24, Revenue: $253MQ2'24, Net income: $114MQ2'24Q3'24, Revenue: $276MQ3'24, Net income: $112MQ3'24Q4'24, Revenue: $279MQ4'24, Net income: $113MQ4'24Q1'25, Revenue: $277MQ1'25, Net income: $109MQ1'25Q2'25, Revenue: $283MQ2'25, Net income: $137MQ2'25Q3'25, Revenue: $312MQ3'25, Net income: $180MQ3'25Q4'25, Revenue: $319MQ4'25, Net income: $165MQ4'25Q1'26, Revenue: $7MQ1'26, Net income: $151MQ1'26Q2'26, Revenue: $14MQ2'26, Net income: $363MQ2'26$0$100M$200M$300M$400MQ3'22, Revenue: $239MQ3'22, Net income: $102MQ4'22, Revenue: $145MQ4'22, Net income: $46MQ4'22Q1'23, Revenue: $218MQ1'23, Net income: $36MQ2'23, Revenue: $250MQ2'23, Net income: $60MQ2'23Q3'23, Revenue: $242MQ3'23, Net income: $91MQ4'23, Revenue: $239MQ4'23, Net income: $55MQ4'23Q1'24, Revenue: $243MQ1'24, Net income: $67MQ2'24, Revenue: $253MQ2'24, Net income: $114MQ2'24Q3'24, Revenue: $276MQ3'24, Net income: $112MQ4'24, Revenue: $279MQ4'24, Net income: $113MQ4'24Q1'25, Revenue: $277MQ1'25, Net income: $109MQ2'25, Revenue: $283MQ2'25, Net income: $137MQ2'25Q3'25, Revenue: $312MQ3'25, Net income: $180MQ4'25, Revenue: $319MQ4'25, Net income: $165MQ4'25Q1'26, Revenue: $7MQ1'26, Net income: $151MQ2'26, Revenue: $14MQ2'26, Net income: $363MQ2'26

Net income losses drawn in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ3'22, Cash and equivalents: $135MQ3'22, Long-term debt: $5.3BQ3'22Q4'22, Cash and equivalents: $297MQ4'22, Long-term debt: $5.3BQ4'22Q1'23, Cash and equivalents: $245MQ1'23, Long-term debt: $5.3BQ1'23Q2'23, Cash and equivalents: $351MQ2'23, Long-term debt: $5.3BQ2'23Q3'23, Cash and equivalents: $555MQ3'23, Long-term debt: $5.3BQ3'23Q4'23, Cash and equivalents: $443MQ4'23, Long-term debt: $5.1BQ4'23Q1'24, Cash and equivalents: $362MQ1'24, Long-term debt: $5.0BQ1'24Q2'24, Cash and equivalents: $35MQ2'24, Long-term debt: $4.7BQ2'24Q3'24, Cash and equivalents: $342MQ3'24, Long-term debt: $4.9BQ3'24Q4'24, Cash and equivalents: $518MQ4'24, Long-term debt: $4.8BQ4'24Q1'25, Cash and equivalents: $368MQ1'25, Long-term debt: $4.4BQ1'25Q2'25, Cash and equivalents: $734MQ2'25, Long-term debt: $5.0BQ2'25Q3'25, Cash and equivalents: $737MQ3'25, Long-term debt: $5.0BQ3'25Q4'25, Cash and equivalents: $27MQ4'25, Long-term debt: $4.3BQ4'25Q1'26, Cash and equivalents: $26MQ1'26Q2'26, Cash and equivalents: $39MQ2'26$0$2B$4B$6BQ3'22, Cash and equivalents: $135MQ3'22, Long-term debt: $5.3BQ4'22, Cash and equivalents: $297MQ4'22, Long-term debt: $5.3BQ4'22Q1'23, Cash and equivalents: $245MQ1'23, Long-term debt: $5.3BQ2'23, Cash and equivalents: $351MQ2'23, Long-term debt: $5.3BQ2'23Q3'23, Cash and equivalents: $555MQ3'23, Long-term debt: $5.3BQ4'23, Cash and equivalents: $443MQ4'23, Long-term debt: $5.1BQ4'23Q1'24, Cash and equivalents: $362MQ1'24, Long-term debt: $5.0BQ2'24, Cash and equivalents: $35MQ2'24, Long-term debt: $4.7BQ2'24Q3'24, Cash and equivalents: $342MQ3'24, Long-term debt: $4.9BQ4'24, Cash and equivalents: $518MQ4'24, Long-term debt: $4.8BQ4'24Q1'25, Cash and equivalents: $368MQ1'25, Long-term debt: $4.4BQ2'25, Cash and equivalents: $734MQ2'25, Long-term debt: $5.0BQ2'25Q3'25, Cash and equivalents: $737MQ3'25, Long-term debt: $5.0BQ4'25, Cash and equivalents: $27MQ4'25, Long-term debt: $4.3BQ4'25Q1'26, Cash and equivalents: $26MQ2'26, Cash and equivalents: $39MQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed July 30, 2026.

Omega Healthcare Investors Inc. income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed Apr 29, 2026Q4 FY2025ended Dec 31, 2025filed Feb 9, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025Q3 FY2024ended Sep 30, 2024filed Oct 31, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue147319312283277279276−95.0%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative4226242423322322+80.1%
Operating income331———281———+17.7%
Other income (expense)2394284537131(1)+553.2%
Pretax income380160171191147115127111+158.0%
Income tax55245433+2.0%
Net income363151165180137109113112+165.6%
Diluted EPS ($)1.190.47—0.590.460.33—0.42+158.7%
Diluted shares (millions)316315—308303295—276—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed July 30, 2026.

Omega Healthcare Investors Inc. balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed Apr 29, 2026Q4 FY2025ended Dec 31, 2025filed Feb 9, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025Q3 FY2024ended Sep 30, 2024filed Oct 31, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents392627737734368518342−94.7%
Short-term investments—————————
Total current assets—————————
Total assets10,01510,23510,04910,59610,5469,7069,8989,572−5.0%
Total current liabilities—————————
Long-term debt——4,2564,9955,0004,4464,8394,858—
Total liabilities4,3724,7804,6095,3525,3574,7745,1675,172−18.4%
Stockholders’ equity5,3915,1915,1815,0364,9884,7414,5374,208+8.1%
Shares outstanding (millions)303298296296295289282270—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed July 30, 2026.

Omega Healthcare Investors Inc. cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 30, 2026Q1 FY2026ended Mar 31, 2026filed Apr 29, 2026Q4 FY2025ended Dec 31, 2025filed Feb 9, 2026Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025Q2 FY2025ended Jun 30, 2025filed Aug 1, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025Q3 FY2024ended Sep 30, 2024filed Oct 31, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow218216231227239182229185−9.0%
Capital expenditures—————————
Free cash flow (CFO − capex)—————————
Depreciation and amortization8284838281807977+1.7%
Share repurchases—————————
Dividends paid200198198198195189181173+2.8%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 9, 2026.

Income statement

Omega Healthcare Investors Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 9, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 12, 2024FY2022ended Dec 31, 2022filed Feb 14, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 11, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Revenue1,1901,0519508781,063892929882908901744505419350292258197194
Cost of revenue——————————————————
Gross profit——————————————————
Research and development——————————————————
Selling, general and administrative1048882696560586448463926222119151212
Operating income——————552498315560411345266215138149116105
Other income (expense)122189935813055725(209)(176)(183)(127)(92)(106)(87)(90)(35)(39)
Pretax income624429255436416162344297106384235221173——588278
Income tax1511654533311————000
Net income59040624242741715934128210036622522117312153588278
Diluted EPS ($)1.941.551.001.801.750.701.581.400.511.901.291.741.461.120.460.520.870.94
Diluted shares (millions)305270250244244235222210207202181127118*108102948475

Balance sheet

Omega Healthcare Investors Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 9, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 12, 2024FY2022ended Dec 31, 2022filed Feb 14, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 11, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Cash and equivalents27518443297211642410869454320720
Short-term investments——————————————————
Total current assets——————————————————
Total assets10,0499,8989,1179,4059,6389,4979,7968,5918,7738,9497,9903,9223,4622,9822,5572,3041,655—
Total current liabilities——————————————————
Long-term debt4,2564,8395,0675,2875,2545,1695,1364,5414,5724,3673,5692,3792,0241,8251,5511,177——
Total liabilities4,6095,1675,3555,6025,5305,4615,4604,8264,8854,7373,8892,5202,1621,9711,6791,300790—
Stockholders’ equity5,1814,5373,5753,6093,9073,8424,1353,4443,5553,8593,7381,4011,3001,0118781,004865788
Shares outstanding (millions)296282245234239232227204199197188139124113104100——

Cash flow statement

Omega Healthcare Investors Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 9, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 12, 2024FY2022ended Dec 31, 2022filed Feb 14, 2023FY2021ended Dec 31, 2021filed Feb 17, 2022FY2020ended Dec 31, 2020filed Feb 22, 2021FY2019ended Dec 31, 2019filed Feb 28, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 23, 2018FY2016ended Dec 31, 2016filed Feb 24, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Feb 27, 2015FY2013ended Dec 31, 2013filed Feb 11, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 27, 2012FY2010ended Dec 31, 2010filed Feb 28, 2011FY2009ended Dec 31, 2009filed Aug 6, 2010FY2008ended Dec 31, 2008filed Aug 6, 2010
Operating cash flow87974961862672270855449957862546433828020817015814789
Capital expenditures——————————————————
Free cash flow (CFO − capex)——————————————————
Depreciation and amortization32530532033234233030228128826721112312911310085——
Share repurchases———142——————————3———
Dividends paid78068564463363861256452950345335825921818216213910998

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$1M
2 purchases by 2 insiders; officers and directors $1M
Sold, twelve months
$0
0 sales by 0 insiders; officers and directors $0

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Golem Lucas M.CHIEF ACCOUNTING OFFICERaward64$39.37$3K1,770Oct 1, 2026
Oct 1, 2026Golem Lucas M.CHIEF ACCOUNTING OFFICERdisposition to issuer3$46.31$1391,767Oct 1, 2026
Aug 7, 2026Egbuonu-Davis LisaDirectorgift5,131$0.00—17,301Aug 11, 2026
Jul 1, 2026Ballew NealCHIEF ACCOUNTING OFFICERaward168$37.25$6K4,676Jul 1, 2026
Jul 1, 2026Ballew NealCHIEF ACCOUNTING OFFICERdisposition to issuer11$47.68$5244,665Jul 1, 2026
Jun 5, 2026Whitman Burke WDirectoraward3,778$43.67$165K47,931Jun 9, 2026
Jun 5, 2026Jacobs Kevin JDirectoraward6,125$43.67$267K46,935Jun 9, 2026
Jun 5, 2026Egbuonu-Davis LisaDirectoraward3,778$43.67$165K22,432Jun 9, 2026
Apr 1, 2026Ballew NealCHIEF ACCOUNTING OFFICERaward168$37.25$6K4,516Apr 1, 2026
Apr 1, 2026Ballew NealCHIEF ACCOUNTING OFFICERdisposition to issuer8$43.82$3514,508Apr 1, 2026
Jan 1, 2026Ballew NealCHIEF ACCOUNTING OFFICERtax withholding12$44.34$5324,348Jan 2, 2026
Jan 1, 2026Ballew NealCHIEF ACCOUNTING OFFICERaward173$35.89$6K4,360Jan 2, 2026
Dec 31, 2025Stephenson Robert OCHIEF FINANCIAL OFFICERgiftindirect31,426$0.00—31,426Jan 5, 2026
Dec 31, 2025Stephenson Robert OCHIEF FINANCIAL OFFICERgift31,426$0.00—147,000Jan 5, 2026
Dec 30, 2025Stephenson Robert OCHIEF FINANCIAL OFFICERgift3,850$0.00—178,426Jan 2, 2026
Nov 6, 2025Gupta VikasChief Investment Officeropen-market buy11,500$42.97$494K13,773Nov 6, 2025
Nov 5, 2025Pickett C TaylorCHIEF EXECUTIVE OFFICER, Directoropen-market buyindirect20,000$43.14$863K20,000Nov 6, 2025
Oct 1, 2025Ballew NealCHIEF ACCOUNTING OFFICERaward201$31.16$6K4,204Oct 1, 2025
Oct 1, 2025Ballew NealCHIEF ACCOUNTING OFFICERtax withholding17$42.22$7184,187Oct 1, 2025
Aug 26, 2025Stephenson Robert OCHIEF FINANCIAL OFFICERgift800$0.00—182,276Aug 28, 2025
Aug 8, 2025Egbuonu-Davis LisaDirectoropen-market sale2,300$40.16$92K18,654Aug 11, 2025
Aug 8, 2025Egbuonu-Davis LisaDirectoropen-market sale200$40.16$8K20,954Aug 11, 2025
Jul 1, 2025Ballew NealCHIEF ACCOUNTING OFFICERtax withholding9$36.65$3304,003Jul 1, 2025
Jul 1, 2025Ballew NealCHIEF ACCOUNTING OFFICERaward200$31.16$6K4,012Jul 1, 2025
Jun 6, 2025Whitman Burke WDirectoraward4,388$37.60$165K44,153Jun 10, 2025

Full insider history for Omega Healthcare Investors Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
OMEGA HEALTHCARE INVESTORS, INC., CIK 888491 on EDGAR
Extract generated
November 4, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: other income FY2018
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: RealEstateRevenueNet, RevenueFromContractWithCustomerExcludingAssessedTax, Revenues
Cost of revenue: not filed
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss, NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: not filed
Total assets: Assets
Total current liabilities: not filed
Long-term debt: LongTermDebt
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/OHI.json